We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
AUM
$104M
AUM Growth
+$6.29M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN icon
1
Biohaven
BHVN
$2.43B
$76.4M 73.72%
2,936,507
BCRX icon
2
BioCryst Pharmaceuticals
BCRX
$2.52B
$27.2M 26.28%
3,846,154
VIRX
3
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.85K ﹤0.01%
3,700

Similar funds

RP Management's Q3 2023 Portfolio in Review

As of Q3 2023, RP Management held 3 positions worth $104M, up 6.5% from $97.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. RP Management opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RP Management's ten largest holdings make up 100% of its $104M portfolio in Q3 2023.
  • RP Management opened 0 new positions and closed 0 in Q3 2023.
  • RP Management's portfolio value rose 6.5% quarter-over-quarter to $104M.

Based on RP Management's 13F filing for Q3 2023, filed 13 Nov 2023.